CD274 and neoplasm: Second, the accuracy of the model should be further improved; more risk factors related to OS could be included in the future, such as preoperative laboratory results and tumor markers other than PD1/PDL1, which may also be significant predictors and prognostic indicators for MIBC disease progression and treatment resistance.